Announcing the launch of Breakthroughs Today, Cures Tomorrow, our 20th anniversary campaign!
For 20 years, NETRF has been advancing research and progress for patients and families facing neuroendocrine cancer. Together, we have fueled breakthroughs once thought impossible — but there is still much more to achieve.
Breakthroughs Today, Cures Tomorrow is our bold next step: a commitment to fund $25 million in leading-edge research by 2030 to transform diagnosis, new treatments, and lives.
The breakthroughs we invest in today will yield tomorrow’s cures — and we can’t do it without you.
"We funded a number of research projects that have now turned into not only trials, but treatments. I'm personally very proud of that, and I'm proud of everyone that has been associated with NETRF because the work has turned into something of value for patients."
Steve Kaufer, NETRF Board of Directors
"NETRF means a lot of hope — for me, for my family, and for other people impacted by the disease."
Brittany Holzhauer
"NETRF funds the best science. And that's a mission we will never let go of — because our patients are counting on us."
Dr. Chrissie Thirlwell, Co-chair, NETRF Board of Scientific Advisors
"This is an insurance policy. My time and money that I give and that our family gives to NETRF is that insurance policy. I have two young grandchildren. I want to see them through all their life cycle events. This is very personal to me."
Todd Gilman, President, NETRF Board of Directors
"Without the support from NETRF, we wouldn’t have been able to bring groundbreaking treatments like CAR-T therapy to clinical trials for patients with neuroendocrine tumors."
Dr. Jennifer Eads, NETRF Board of Scientific Advisors
"It's been an incredible evolution. NETRF has brought me into their community, which includes patients and researchers, and others who are trying to foster a coordinated effort as a community to solve this dilemma of this disease."
Elaine Nord, NETRF Board of Directors
"If I look at what NETRF means to me, it is the ability to bring basic research together with clinicians to try to bring that bench to bedside, and at the same time also provide bedside support for our patient community."
Josh Mailman, NETRF Board of Directors
Detecting neuroendocrine cancers sooner to save more lives.
Advancing innovative treatments to improve survival and quality of life.
Personalizing care to each patient’s unique journey.
From breakthroughs today to cures tomorrow — every discovery, every advancement, every life changed is made possible by you.
Thank you for standing with us. Our future starts now.
